Key facts
- This page summarizes Elizabeth E. Tallett's Form 4 filing for Elevance Health, Inc. (ELV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 May 2024, 16:26.
Elizabeth E. Tallett - 15 May 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)
- Reporting relationship
- Director
- Issuer ticker
- ELV
- Reported as of
- 15 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 May 2024, 16:26:50 UTC
- Prior SEC filing
- 07 May 2024
- Next SEC filing
- 01 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen S. Kiefer, Attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Elizabeth E. Tallett filed Form 4 for Elevance Health, Inc. (ELV) on 17 May 2024.
Change
- Previous filing in this sequence was filed on 07 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +388
- Change %
- +3.9%
- Price
- $0.000000
- Shares after
- 10,291
- Date
- 15 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2
The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.